cbdMD (YCBD) Non-Current Assets (2016 - 2026)
cbdMD (YCBD) posted Non-Current Assets of $3.6 million for Q4 2025, down 6.51% sequentially from $3.9 million in Q3 2025, and down 30.21% YoY from $5.2 million in Q4 2024.
cbdMD (YCBD) Non-Current Assets (2016 - 2026) Analysis & Trends
cbdMD has reported Non-Current Assets for 10 years, with the latest figure at $3.6 million in Q4 2025.
- Quarterly Non-Current Assets fell 30.21% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.5 million (down 28.35% YoY) and the FY2025 annual result came in at $3.9 million, down 7.72% from the prior year.
- Non-Current Assets slipped to $3.6 million in Q4 2025 per YCBD's latest filing, from $3.9 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $88.4 million in Q3 2021 and troughed at $3.6 million in Q4 2025.
- A 5-year average of $29.3 million and a median of $15.5 million in 2023 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Non-Current Assets grew 1.44% in 2021, then slumped 71.96% in 2022.
- Over 5 years, Non-Current Assets stood at $69.6 million in 2021, then sank by 65.26% to $24.2 million in 2022, then slumped by 68.06% to $7.7 million in 2023, then slumped by 32.95% to $5.2 million in 2024, then sank by 30.21% to $3.6 million in 2025.
- According to Business Quant data, Non-Current Assets over the past three periods registered $3.6 million, $3.9 million, and $4.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 43.50 Bn | 39.84 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 32.42 Bn | 30.75 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 21.99 Bn | 19.33 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.96 Bn | 18.08 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 2.96 Bn |
| 10 | cbdMD | 5.39 Mn | 3.27 Mn | 3.04 Mn | 5.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.45 Mn |
| Dec 31, 2025 | 3.62 Mn |
| Sep 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.75 Mn |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 4.19 Mn |
| Jun 30, 2024 | 6.55 Mn |
| Mar 31, 2024 | 7.14 Mn |
| Dec 31, 2023 | 7.73 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 22.88 Mn |
| Mar 31, 2023 | 23.54 Mn |
| Dec 31, 2022 | 24.20 Mn |
| Sep 30, 2022 | 24.78 Mn |
| Jun 30, 2022 | 37.28 Mn |
| Mar 31, 2022 | 68.66 Mn |
| Dec 31, 2021 | 69.65 Mn |
| Sep 30, 2021 | 88.38 Mn |
| Jun 30, 2021 | 85.54 Mn |